| 1 |
32636633 | Novel Melatonin, Estrogen, and Progesterone Hormone Therapy Demonstrates Anti-Cancer Actions in MCF-7 and MDA-MB-231 Breast Cancer Cells. | 2020 |
1 |
| 2 |
32772021 | Melatonin Administered before or after a Cytotoxic Drug Increases Mammary Cancer Stabilization Rates in HER2/Neu Mice. | 2020 |
2 |
| 3 |
31355130 | Co-administering Melatonin With an Estradiol-Progesterone Menopausal Hormone Therapy Represses Mammary Cancer Development in a Mouse Model of HER2-Positive Breast Cancer. | 2019 |
2 |
| 4 |
16678784 | Melatonin as antioxidant, geroprotector and anticarcinogen. | 2006 May-Jun |
1 |
| 5 |
15501020 | Stressors and antistressors: how do they influence life span in HER-2/neu transgenic mice? | 2004 Oct |
1 |
| 6 |
12471612 | The effect of melatonin treatment regimen on mammary adenocarcinoma development in HER-2/neu transgenic mice. | 2003 Jan 20 |
4 |
| 7 |
12790777 | Melatonin and mammary cancer: a short review. | 2003 Jun |
1 |
| 8 |
11781542 | The effect of light regimen and melatonin on the development of spontaneous mammary tumors in HER-2/neu transgenic mice is related to a downregulation of HER-2/neu gene expression. | 2001 Dec |
9 |